Hemodynamic Monitoring Market Report by Product, Monitoring, End-User, and Region 2024-2032
세계의 혈행동태 모니터링 시장 규모는 2023년에 11억 5,000만 달러에 달했습니다. 향후 IMARC Group은 시장이 2032년까지 16억 8,000만 달러에 달하며, 2024-2032년 4.2%의 성장률(CAGR)을 보일 것으로 예측하고 있습니다.
혈행동태 모니터링은 심장, 정맥, 동맥에 작용하는 혈류와 압력을 측정하는 과정을 말합니다. 혈행동태 파라미터와 산소 공급을 평가하고 최적화하여 다양한 심폐 질환의 진단 및 치료, 중증 환자의 결과를 개선하는 데 도움이 됩니다. 수년간 혈행동태 모니터링은 심박출량(CO)의 기본적인 추적에서 혈압, 혈액량, 체액 균형과 같은 다양한 변수에 대한 정보를 제공하는 첨단 장비로 발전해 왔습니다.
수년 동안 심장 기능 장애를 앓고 있는 사람들의 수가 증가하고 있으며, 그 결과 혈행동태이 불안정해져 결국 장기 부전으로 이어집니다. 그 결과 전 세계에서 혈행동태 모니터링에 대한 수요가 크게 증가했습니다. 이에 따라 비침습적 동맥압 파형 분석을 통해 얻을 수 있는 보다 혁신적이고 보정되지 않은 비침습적 CO 측정의 도입도 시장 성장에 기여하고 있습니다. 또한 환자의 예후를 개선하고 중증 환자의 조직 저산소증, 쇼크, 다발성 장기 부전을 방지하기 위해 의료계 전반에서 혈행동태 모니터링의 사용이 증가하고 있습니다. 광범위한 연구개발(R&D) 활동은 또 다른 주요 성장 동력으로 작용하고 있습니다. 제조업체들은 보다 간편하고 저렴한 가격의 저침습적 및 비침습적 혈행동태 모니터링 시스템을 개발하여 보다 정확한 결과를 제공하기 위해 노력하고 있습니다. 이 외에도 정부 및 민간 부문의 의료비 지출 증가와 기술 발전은 향후 수년간 시장 전망을 더욱 밝게할 것으로 예상됩니다.
이 보고서에서 다룬 주요 질문
- 세계 혈행동태 모니터링 시장은 지금까지 어떻게 성장해왔고, 앞으로 어떻게 발전할 것인가?
- 주요 지역 시장은?
- COVID-19가 세계 혈행동태 모니터링 시장에 미치는 영향은?
- 제품별 시장 분석은?
- 모니터링별 시장 분석은?
- 산업 밸류체인의 다양한 단계는?
- 업계의 주요 촉진요인과 과제는?
- 세계 혈행동태 모니터링 산업의 구조와 주요 기업은?
- 업계의 경쟁은 어느 정도인가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 개요
제4장 서론
제5장 세계의 혈행 동태 모니터링 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 내역 : 제품별
제7장 시장 내역 : 모니터링
- 침습적 모니터링
- 저침습 모니터링
- 비침습적 모니터링
제8장 시장 내역 : 최종사용자별
- 병원
- 진료소 및 외래 진료 센터
- 홈케어 환경
- 기타
제9장 시장 내역 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
- 개요
- 바이어의 교섭력
- 공급 기업의 교섭력
- 경쟁의 정도
- 신규 진출업체의 위협
- 대체품의 위협
제13장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업의 개요
- Edwards Lifesciences Corporation
- Lidco Group PLC
- Deltex Medical Group PLC
- Pulsion Medical Systems SE
- GE Healthcare
- Osypka Medical GmbH
- Tensys Medical
- Teleflex Incorporated
- ICU Medical Inc.
- Argon Medical
- Schwarzer Cardiotek GmbH
KSA
The global hemodynamic monitoring market size reached US$ 1.15 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1.68 Billion by 2032, exhibiting a growth rate (CAGR) of 4.2% during 2024-2032.
Hemodynamic monitoring refers to the process of measuring the blood flow and pressure exerted in the heart, veins and arteries. It enables the assessment and optimization of hemodynamic parameters and oxygen delivery, which helps in diagnosing and treating various cardiopulmonary conditions and improving outcomes in critically ill patients. Over the years, hemodynamic monitoring has evolved from basic tracking of cardiac output (CO) to advanced devices that provide information about a wide array of variables, like blood pressure, blood volume and fluid balance.
Over the years, there has been a rise in the number of people suffering from cardiac dysfunction, which results in hemodynamic instability, thus ultimately leading to organ failure. Consequently, the demand for hemodynamic monitoring has significantly increased across the globe. In line with this, the introduction of more innovative, uncalibrated and non-invasive CO measurements obtained through the analysis of a non-invasive arterial pressure waveform is also contributing to the market growth. Furthermore, hemodynamic monitoring is being increasingly used across the healthcare sector to improve patient outcome and combat tissue hypoxia, shock and multiorgan failure in critically ill patients. Extensive research and development (R&D) activities act as another major growth-inducing factor. Manufacturers are undertaking initiatives for the development of simpler minimally- and non-invasive hemodynamic monitoring systems at affordable prices, which will offer more precise results. Other factors, rising healthcare expenditure by both government and private sectors and technological advancements, are further expected to create a positive outlook for the market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hemodynamic monitoring market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, monitoring and end-user.
Breakup by Product:
Disposables
Monitors
Others
Breakup by Monitoring:
Invasive Monitoring
Minimally Invasive Monitoring
Noninvasive Monitoring
Breakup by End-User:
Hospitals
Clinics and Ambulatory Care Centers
Home Care Settings
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Edwards Lifesciences Corporation, Lidco Group PLC, Deltex Medical Group PLC, Pulsion Medical Systems SE, GE Healthcare, Osypka Medical GmbH, Tensys Medical, Teleflex Incorporated, ICU Medical Inc., Argon Medical, Schwarzer Cardiotek GmbH, etc.
Key Questions Answered in This Report:
- How has the global hemodynamic monitoring market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global hemodynamic monitoring market?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the monitoring?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global hemodynamic monitoring industry and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Hemodynamic Monitoring Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Disposables
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Monitors
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Monitoring
- 7.1 Invasive Monitoring
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Minimally Invasive Monitoring
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Noninvasive Monitoring
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by End-User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Clinics and Ambulatory Care Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Home Care Settings
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Edwards Lifesciences Corporation
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 Lidco Group PLC
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.3 Deltex Medical Group PLC
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.4 Pulsion Medical Systems SE
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.5 GE Healthcare
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.6 Osypka Medical GmbH
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.7 Tensys Medical
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.8 Teleflex Incorporated
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.9 ICU Medical Inc.
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.10 Argon Medical
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.11 Schwarzer Cardiotek GmbH
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
